Background-There is speculation that the volume of percutaneous coronary interventions (PCIs) Key Words: angiography Ⅲ catheterization Ⅲ epidemiology Ⅲ angioplasty Ⅲ revascularization S ince the development of coronary angioplasty Ͼ3 decades ago, there have been several studies that have cited both an increase in percutaneous coronary intervention (PCI) and a decrease in coronary artery bypass graft (CABG) surgery volumes in the treatment of coronary artery disease within the United States and abroad. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] There has been speculation that the volume of PCIs has started to decline recently, however, in light of the increasing use of drug-eluting stents (DES), advances in medical therapy, and the publication of data from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial demonstrating that coronary revascularization does not reduce the risk of major cardiovascular events over and above optimal medical therapy in patients with stable angina. 11, 12 We analyzed Centers for Medicaid & Medicare Services procedure billing data from 2001 to 2009 to report trends in cardiac catheterizations (diagnostic and interventional), use of PCI (angioplasty and stents), CABG surgeries, and the use of intravascular ultrasound (IVUS) and fractional flow reserve (FFR) during angiography.
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Methods
This retrospective study used data from the Centers for Medicare & Medicaid Services from 2001 to 2009 through the Medicare utilization statistics data set, Part B. Using billed American Medical Association Current Procedural Terminology (CPT) codes from that period, the total number of diagnostic catheterizations (CPT codes 93508 to 93529), PCIs, and CABG (CPT codes 33510 to 33536) surgeries were compiled. PCI was broken down into angioplasty (CPT codes 92982 and 92984; used as a primary treatment modality, not in combination with other therapies) and stenting (both single [CPT code 92980] and multivessel [CPT code 92981] stenting). Diagnostic catheterizations were defined as procedures in which only coronary angiography was performed; the angiographic component of PCI procedures was not included in this number. Diagnostic catheterization and PCI rates for a given year were then combined into a category called "total catheterizations." The total CABG and PCI rates for a given year comprised the category "total coronary revascularizations."
For reimbursement purposes, Medicare recognizes 3 coronary arteries: right coronary, left circumflex coronary, and left anterior descending coronary. In multivessel PCI, it is possible that a physician may report up to 3 percutaneous interventions if an intervention is performed in each of the 3 coronary arteries or their branches. The first reported procedure must use a primary code (CPT codes 92980 and 92982) corresponding to the most complex procedure performed. The procedures performed in the other 1 or 2 coronary arteries (including their branches) are reported with the CPT add-on codes (CPT codes 92981 and 92984). Therefore, multivessel PCI, as per Medicare billing guidelines, was defined as intervention in a vessel different from the vessel in which an initial stent was placed, billed separately and in addition to the initial vessel that received intervention. This definition differentiated multivessel stenting from both single-vessel stenting and multiple stents being placed within a single vessel (which was billed as single-vessel stenting). The total number of annual fee-for-service Medicare beneficiaries during this period was gathered from the Annual Reports of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds during this period. Using these numbers as denominators, each procedure was reported per 1000 Medicare beneficiaries for each given year to account for annual changes in this population. Similar data on the use of IVUS (CPT codes 92978 and 92979) and FFR (CPT codes 93571 and 93572) during angiography also was collected on the basis of billing codes. Notably, data on IVUS use during 2004 was not available because Medicare only released data for high-volume procedures for that year; thus, IVUS did not qualify. Because this research used a limited data set with deidentified information, the University of Washington Institutional Review Board waived the formal application for approval to perform human subject research for this project.
WHAT IS KNOWN

Results
The total number of coronary procedures billed each year between 2001 and 2009 in the Medicare population are shown in the Table; procedures per 1000 Medicare beneficiaries are shown in Figure 1 . The year-to-year percent change in procedures per 1000 beneficiaries is shown in Figure 2 . Although the overall number of diagnostic cathe- (Table) . , demonstrating that the rate of decline in CABG was greater than PCI over the entire period. The number of multivessel stenting procedures remained relatively constant over time at Ϸ12% of PCIs using stents (Table) .
IVUS and FFR use per catheterization during this time period are shown in 
Discussion
The most recent epidemiological data from 2007 showed that the overall death rate from cardiovascular disease in the United States was 204.3 per 100 000 persons, making it the leading cause of death in both men and women. 13 However, the age-adjusted death rate for coronary heart disease has been steadily decreasing since the 1980s, likely as a result of improved risk factor modification and cardiovascular therapies. 14 The trends in coronary catheterization volumes observed in our study from 2001 to 2004 are consistent with previous reports that showed steady increases in PCI volumes during that period. 15 Our data also show that the total and per-beneficiary numbers of diagnostic and interventional catheterizations in the Medicare population have been decreasing steadily since 2004. Although there was stabilization in the number of catheterizations in 2009, the overall trend from 2004 to 2009 remained in decline, with the total number of coronary revascularizations (PCI and CABG combined) declining over the 9-year period studied. The rate of decline in CABG surgeries continued to outpace that of the decline in PCI.
There are numerous possible explanations about why coronary catheterization rates have started to decline over the past several years. One explanation might be increased treatment of atherosclerotic risk factors over the past decade. It has been previously estimated that 44% of the reduction in US deaths due to coronary heart disease from 1980 to 2000 was due to risk factor modification. 14 The Centers for Disease Control and Prevention recently published a report that showed that the prevalence of smoking among US adults decreased by 3.5% from 1998 to 2008. 16 There also are data showing that an increasing percentage of the US population is achieving target blood pressure and cholesterol goals. 17, 18 The Medical Expenditure Panel Survey published a report in 2008 that showed nearly a doubling in statin prescriptions from 2000 to 2005 (89.7 versus 173.7 million) in the US population. 19 There is also evidence for increasing prescriptions for ␤-blockers among patients with known coronary artery disease. 20 Another possible explanation for these trends could be the increasing use of DES during this period. After their initial approval by the US Food and Drug Administration in 2003, DES were used in as many as 90% of all PCIs in the United States by 2006. 21 In a similar Medicare population, it was reported that the use of bare-metal stents in PCI decreased from 89% in 2001 to 19% in 2004. Similarly, the use of DES increased to 75% of all stents placed in this population in 2008. Concurrently, significant reductions were found in the need for repeat revascularization in this population over that period. 15 The reduction of in-stent restenosis from the use of DES could have led to fewer repeat angiograms and repeat revascularization procedures. On the other hand, the concerns for increased stent thrombosis of DES in the latter part of this period also may have contributed to the decrease in PCI seen after 2004. 22 Additionally, it is possible that more patients with stable angina are being primarily medically managed or evaluated with noninvasive imaging before diagnostic catheterization or 
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coronary revascularization. In a recent single-center study, patients referred for angiography following publication of the COURAGE trial were more often treated with aggressive disease-modifying agents before referral for catheterization than were pre-COURAGE patients. In the same study, it also was noted that patients with stable angina and significant coronary artery disease on angiography were more likely to receive medical therapy rather than revascularization as initial treatment management post-COURAGE. 20 An increased use of primary medical management along with an increasing use of noninvasive coronary imaging 23 likely have contributed to decreasing catheterization and revascularization rates, although the COURAGE trial itself would not explain our results because it was not published until 2007. During the same period in which PCI rates have been decreasing, the rates of IVUS and FFR use per catheterization have been steadily increasing within the Medicare population. This increased use could be related to the increased complexity of coronary artery disease being managed percutaneously. Conversely, the increased hemodynamic assessment of coronary lesions using FFR and anatomic assessment using IVUS could have contributed to the decrease in PCI. However, these changes in procedure volume were comparatively small, and their contribution to the overall changes in revascularization volumes was likely trivial.
There are several limitations to our study. First, patientlevel data, the indication for each type of procedure, procedure priority (emergent versus nonemergent), and stent type (bare metal versus drug eluting) were not available for our study population, making it difficult to evaluate the contribution of these factors on the observed trends. Another limitation, inherent to studies based on physician billing codes, is that we were unable to account for the contribution of improper billing on our results. Underbilling due to accidental physician omission or overbilling for multivessel PCI (eg, billing for multivessel PCI when stenting the left anterior descending coronary artery plus a diagonal artery, which should be billed as single-vessel PCI) are 2 such examples. Finally, the older population within Medicare may not reflect the patient population of the United States as whole because trends in the use of diagnostic and interventional cardiac procedures may differ between older and younger patients. Nevertheless, Medicare is the largest insurance carrier in the United States and is likely representative of national trends. 15 In summary, the use of diagnostic and interventional coronary catheterizations within the Medicare population has been steadily declining since 2004. Although there was some stabilization of these trends in 2009, they are reminiscent of the decline in CABG rates that started in the late 1980s, which was initially attributed to the expanding use of PCI. Given the declines in both CABG and PCI since 2004, the use of PCI does not appear to entirely explain the decline in CABG rates. Potentially, the decline in CABG surgery volume was simply the canary in the coal mine that signaled larger-scale reductions in the need for coronary revascularization as risk factor modification and cardiovascular therapeutics continue to improve.
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